Lamisil (Terbinafine Hydrochloride)

Terbinafine blocks the fungal enzyme squalene epoxidase, which is essential for producing ergosterol, a key component of fungal cell membranes. Inhibiting this step causes toxic buildup of squalene and loss of ergosterol, disrupting membrane integrity and leading to fungal cell death. This mechanism provides a fungicidal effect against the organisms that cause skin infections.

The dosage of Lamisil is determined by the prescribing healthcare professional based on the specific infection, severity, and patient characteristics. Typically, a thin layer of the cream is applied once daily to the affected area for the duration recommended by the prescriber, which may range from one to two weeks for most superficial infections.

Safety data for topical terbinafine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Lamisil with their healthcare provider before starting treatment.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing a quotation, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lamisil (terbinafine) belongs to the allylamine class and acts by inhibiting squalene epoxidase, whereas azoles block the enzyme lanosterol 14α‑demethylase. Terbinafine is often fungicidal and may achieve faster clearance of dermatophytes, while azoles are generally fungistatic. Choice of therapy depends on infection type, resistance patterns, patient tolerance and prescriber preference.

Lamisil should be stored at room temperature, typically below 25 °C (77 °F). Keep the cream in its original container, tightly closed, and protect it from moisture, excessive heat and direct sunlight. Do not freeze the product, and keep it out of reach of children.

Before applying, wash and thoroughly dry the affected skin area. Apply a thin, even layer of the cream to the lesion and a small margin of surrounding healthy skin, once daily, as directed by the prescriber. Wash hands after application unless the hands are being treated, and avoid covering the area with occlusive dressings unless instructed.

Although rare, serious adverse reactions can include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and signs of liver injury such as jaundice or elevated liver enzymes. Patients should seek immediate medical attention if they experience widespread rash, blistering, swelling, or symptoms suggestive of hepatic dysfunction.

Lamisil should not be used by individuals with a known hypersensitivity to terbinafine, other allylamine antifungals, or any of the cream’s excipients. It is also contraindicated on severely damaged, ulcerated or extensively broken skin, and should be avoided in patients who are pregnant or breastfeeding unless the prescriber determines that the benefits outweigh potential risks.